DREW WATSON

The resulting revolution in genomics, informatics and functional biology has enabled a new era in personalized medicine and Drew remains an active participant. Drew is currently working with companies such as Genomic Health to develop molecular diagnostics that enable physicians to confidently identify patients who are most likely to benefit from aggressive treatments, such as chemotherapy or organ transplantation. On the biopharmaceutical development side, Drew is working with companies such as Bullet Biotechnology, to develop novel drugs tailored specifically to individual patients.

Also known as: Drew

Primary location: Menlo Park United States